Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

CROs and service providers at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

66 CROs and service providers are at ASH 2026 — 41 presentations on the program and 44 with a booth in the exhibit hall. Most represented: Sarah Cannon Research Institute (4 on the program), Parexel (4 on the program), Medscape (2 on the program). 47 of them have their own page in this guide. As of Nov 10, 2026.

All 1,934 organizations at ASH 2026 →

Topic
Top represented
Showing 1–8 of 66 organizations
OrganizationASH 2026 Attendance
CROs & services
Oncology research organization running cancer clinical trials in community settings for more than 30 years.
Booth
Exhibiting at Booth 2316
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
11:00am–2:00pm
Best Practice Use of Bispecific Antibodies in Non-Hodgkin Lymphoma – A Second Opinion Case Review
Difficult non-Hodgkin lymphoma cases treated or considered for bispecific antibodies, with reviews of recent data, current practice, and ongoing trials.
Lymphoma · New drugs
Parexel
Durham, NC
CROs & services
Global contract research organization providing clinical trial, regulatory consulting and real-world evidence services to biopharma.
Booth
Exhibiting at Booth 2457
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Medscape
Newark, NJ
CROs & services
Online news, clinical reference tools and continuing medical education for oncology and hematology professionals.
Booth
Exhibiting at Booth 3239
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Analysis Group
Boston, MA
CROs & services
An economic consulting firm headquartered in Boston, Massachusetts.
AE
Arensia Exploratory Medicine
Kyiv, Ukraine
CROs & services
Clinical research organization in Kyiv, Ukraine.
GH
Greco-Hainsworth Tennessee Oncology Centers for Research
Nashville, TN
CROs & services
Oncology clinical research organization in Nashville, Tennessee.
CROs & services
Accredited continuing medical education provider producing live and online programs for clinicians, including hematology and oncology symposia.
Symposium
Fri Dec 11
7:00am–10:00am
Next in Line for Relapsed/Refractory Myeloma: Sequencing Strategies With T-Cell Engagers, Next-Generation CAR-T, and Innovative MOAs
Sequencing relapsed myeloma treatments as next-generation CAR-T, multi-target T-cell engagers, and new drug classes arrive, plus managing their toxicity.
Myeloma · New drugs
Symposium
Fri Dec 11
11:00am–2:00pm
Advancing Bispecific Pathways in ALL: How Clinical Experience and New Science are Informing Off-the-Shelf Innovation
Bispecific T-cell engagers in B-cell acute lymphoblastic leukemia, including gentler next-generation versions for patients unsuited to or relapsing after CAR-T.
Leukemias · New drugs
Symposium
Fri Dec 11
11:00am–2:00pm
Realigning Modern Care in MCL: Guidance on the Next Wave of Advances With BTK Inhibitor Options and New Targeted Strategies
Mantle cell lymphoma care built on Bruton tyrosine kinase inhibitors up front, with newer kinase and Bcl-2 inhibitors or CAR-T after relapse.
Lymphoma · New drugs
Symposium
Fri Dec 11
3:00pm–6:00pm
FAST Track to Enhanced CLL Outcomes: Finite Therapy Advances With BTK Inhibitors as New STandards for Frontline Treatment
Time-limited frontline chronic lymphocytic leukemia treatment pairing Bruton tyrosine kinase and Bcl-2 inhibitors, tailored to patient goals and risk.
Lymphoma · New drugs
Symposium
Fri Dec 11
3:00pm–6:00pm
The Rising Tide of Bispecifics in NHL: Off-the-Shelf Opportunities From Later-Line to Frontline Care
Bispecific antibodies moving from late to early treatment of non-Hodgkin lymphoma, with outpatient step-up dosing and control of immune side effects.
Lymphoma · New drugs
Symposium
Fri Dec 11
7:00pm–10:00pm
Accelerating CARs for Lymphoma: Expert Workshops on CAR-T Standards, Sequencing, and Emerging Cellular Therapy Platforms
CAR-T as standard lymphoma care and what comes next, including dual-target, faster-manufactured, and in vivo versions that could widen patient access.
Lymphoma · Cell & gene
CROs & services
Accredited medical education company (Clinical Education Alliance) running clinician education programs and satellite symposia, with data and market-research services.
Booth
Exhibiting at Booth 2123
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
11:00am–2:00pm
CAR T-Cell Agent Integration in Lymphoma: A Masterclass for Real-World Implementation
CAR-T for relapsed B-cell lymphomas, from patient selection and referral to managing immune and nerve toxicities, survivorship, and off-the-shelf products.
Lymphoma · Cell & gene
Symposium
Fri Dec 11
11:00am–2:00pm
CLL Challenge! Interrogating the Latest Evidence on Patient Priorities and Novel Targeted Therapies
Shared decision-making in chronic lymphocytic leukemia, using biomarker testing to choose among fixed-duration, continuous, and newer targeted treatments.
Lymphoma
Symposium
Fri Dec 11
11:00am–2:00pm
Mastering Systemic Mastocytosis: Diagnostic Criteria, Risk Stratification, and Patient-Centered Treatment Across Indolent and Advanced Disease
Diagnosing systemic mastocytosis, separating indolent from advanced disease, preventing anaphylaxis, and choosing between symptom control and Kit-targeted drugs.
Leukemias
Symposium
Fri Dec 11
3:00pm–6:00pm
Myeloma Challenge! Test Your Knowledge of Updated Guidelines and Evidence-Based Practice
Guideline-based myeloma care from smoldering disease to late relapse, including three- or four-drug regimens, residual disease testing, and newer immunotherapies.
Symposium hosted by National Comprehensive Cancer Network
Myeloma
Symposium
Fri Dec 11
3:00pm–6:00pm
Optimizing Integration of BsAb-Based Therapies for FL and DLBCL: Expert Perspectives on New Standards and Future Directions
How bispecific antibodies for follicular and diffuse large B-cell lymphoma differ in structure, dosing, and safety, and how to sequence them in community care.
Lymphoma · New drugs

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from CROs and service providers

Tell us what you sell and we’ll find the people at these CROs and service providers most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse ASH 2026 by

Exhibit hall

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction